World's Best Scientists 2026 revealed!
Jean-Michel Coindre

Jean-Michel Coindre

D-Index & Metrics

Medicine

D-Index
111
Citations
40132
World Ranking
5380
National Ranking
154

Jean-Michel Coindre publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jean-Michel Coindre sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 497 publications — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jean-Michel Coindre D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jean-Michel Coindre sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 111 D-Index — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jean-Michel Coindre is affiliated with the University of Bordeaux in France. Their research primarily focuses on the field of Medicine, with particular expertise in Pulmonary and Respiratory Medicine, Oncology, and Pathology and Forensic Medicine. Additional areas of study include Cancer Research and Rheumatology.

The main topics addressed in their work cover multiple aspects of cancer diagnosis and treatment, with a substantial focus on sarcoma and vascular tumors. Their specific research interests include:

  • Sarcoma Diagnosis and Treatment
  • Vascular Tumors and Angiosarcomas
  • Lymphoma Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Colorectal and Anal Carcinomas
  • Gastrointestinal Tumor Research and Treatment
  • Soft tissue tumor case studies

The scientist has contributed to numerous academic publications, often collaborating with other researchers. Frequent coauthors include François Le Loarer, Jean-Yves Blay, Sophie Le Guellec, Marie Karanian, and Gonzague de Pinieux.

Jean-Michel Coindre has published extensively in well-known scientific journals and venues, including:

  • Cancers
  • Modern Pathology
  • The American Journal of Surgical Pathology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Annals of Oncology

Recent notable papers authored or coauthored by Jean-Michel Coindre include:

  • "Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network", 2021, PLoS ONE
  • "Incidence and time trends of sarcoma (2000-2013): results from the French network of cancer registries (FRANCIM)", 2020, BMC Cancer
  • "NFATc2-rearranged sarcomas: clinicopathologic, molecular, and cytogenetic study of 7 cases with evidence of AGGRECAN as a novel diagnostic marker", 2020, Modern Pathology
  • "Assessment of Safety and Efficacy of Combined Trabectedin and Low-Dose Radiotherapy for Patients With Metastatic Soft-Tissue Sarcomas", 2020, JAMA Oncology
  • "Improved nationwide survival of sarcoma patients with a network of reference centers", 2024, Annals of Oncology

Best Publications

  • Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group.

    Jean-Michel Coindre;Philippe Terrier;Louis Guillou;Viviane Le Doussal

  • MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data

    Matthieu Bui Nguyen Binh;Xavier Sastre-Garau;Louis Guillou;Gonzague de Pinieux

  • Prognostic factors in adult patients with locally controlled soft tissue sarcoma. A study of 546 patients from the French Federation of Cancer Centers Sarcoma Group.

    J M Coindre;P Terrier;N B Bui;F Bonichon

  • "Proximal-type" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series

    Louis Guillou;Catherine Wadden;Jean-Michel Coindre;Thomas Krausz

  • Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma

    Marie Pierre Simon;Florence Pedeutour;Nicolas Sirvent;Josiane Grosgeorge

  • The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes

    Alexander Marx;John K.C. Chan;Jean-Michel Coindre;Frank Detterbeck

  • Tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphoma and advanced solid tumours: a first-in-human, open-label, phase 1 study

    Antoine Italiano;Jean-Charles Soria;Maud Toulmonde;Jean-Marie Michot

  • Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial.

    Alessandro Gronchi;Stefano Ferrari;Vittorio Quagliuolo;Javier Martin Broto

  • Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity

    Frédéric Chibon;Pauline Lagarde;Sébastien Salas;Gaëlle Pérot

  • A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion

    Gaëlle Pierron;Franck Tirode;Carlo Lucchesi;Stéphanie Reynaud

  • High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas

    Antoine Italiano;Yun Shao Sung;Lei Zhang;Samuel Singer

  • Detection of MDM2-CDK4 amplification by fluorescence in situ hybridization in 200 paraffin-embedded tumor samples: utility in diagnosing adipocytic lesions and comparison with immunohistochemistry and real-time PCR.

    Nicolas Sirvent;Jean-Michel Coindre;Georges Maire;Isabelle Hostein

  • Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors

    Nicolas F. Delahaye;Sylvie Rusakiewicz;Sylvie Rusakiewicz;Isabelle Martins;Cédric Ménard;Cédric Ménard

  • Prognostic Factors Influencing Progression-Free Survival Determined From a Series of Sporadic Desmoid Tumors: A Wait-and-See Policy According to Tumor Presentation

    Sébastien Salas;Armelle Dufresne;Binh Bui;Jean-Yves Blay

  • Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group.

    Louis Guillou;Jean Benhattar;Carole Gengler;Gabrielle Gallagher

  • Histologic Grade, But Not SYT-SSX Fusion Type, Is an Important Prognostic Factor in Patients With Synovial Sarcoma: A Multicenter, Retrospective Analysis

    Louis Guillou;Jean Benhattar;Françoise Bonichon;Gabrielle Gallagher

  • MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema

    Johanna Manner;Bernhard Radlwimmer;Peter Hohenberger;Katharina Mössinger

  • Prognostic Factors in Localized Primary Synovial Sarcoma: A Multicenter Study of 128 Adult Patients

    Martine Trassard;Viviane Le Doussal;Kamel Hacène;Philippe Terrier

  • Trends in survival for patients with metastatic soft-tissue sarcoma†

    Antoine Italiano;Simone Mathoulin-Pelissier;Axel Le Cesne;Philippe Terrier

  • Improved survival using specialized multidisciplinary board in sarcoma patients.

    J.-Y. Blay;P. Soibinet;N. Penel;E. Bompas

Frequent Co-Authors

Jean-Yves Blay
Jean-Yves Blay Claude Bernard University Lyon 1
Antoine Italiano
Antoine Italiano University of Bordeaux
Alain Aurias
Alain Aurias Institute Curie
Florence Pedeutour
Florence Pedeutour Grenoble Alpes University
Axel Le Cesne
Axel Le Cesne Institut Gustave Roussy
Isabelle Ray-Coquard
Isabelle Ray-Coquard Claude Bernard University Lyon 1
Christine Chevreau
Christine Chevreau DuPont (United States)
Jean-Yves Scoazec
Jean-Yves Scoazec Grenoble Alpes University
Olivier Delattre
Olivier Delattre PSL University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens the door to diverse healthcare careers, and online education is helping more students and professionals get started or advance. For those wanting to join the workforce quickly, lpn online programs offer efficient pathways to become a Licensed Practical Nurse, providing hands-on experience and foundational medical knowledge in a flexible format.

If you're a registered nurse aiming for specialized roles, the shortest post master's pmhnp online programs prepare you for advanced psychiatric and mental health practice swiftly, making it easier to balance work, study, and personal commitments.

For students interested in healthcare outside of direct patient care, a bachelors in health administration can provide a stepping stone into the management and operational side of hospitals, clinics, or public health organizations. Postgraduate learners can further boost their career prospects and earning potential by researching masters in healthcare administration cost to find affordable, reputable programs.

These online degree options offer valuable alternatives and complement traditional medical pathways, supporting the varied goals of today's healthcare learners.

Best Scientists Citing Jean-Michel Coindre

Trending Scientists

Recently Published Articles